The #1 prescribed daily disposable around the world satisfies a broad range of patients

Astigmatism affects nearly half of the population1

Astigmatic patients need a contact lens designed to meet their specific needs

Chart showing 47% of patients show astigmatism in at least one eye

47% of patients show astigmatism in at least one eye*

Image showing woman experiencing visual discomfort

Uncorrected astigmatism can lead to symptoms of visual discomfort2

Innovative Technology

BLINK STABILIZED® Design

Our exclusive design helps provide clear and stable vision by harnessing the natural power of the blinking eye**. The eyelid interacts with stabilization zones with every blink.  

Blink stabilized designed daily contacts for astigmatism

Dual Action Technology

1-DAY ACUVUE® MOIST for ASTIGMATISM uses Dual Action Technology to specifically address dryness and irritation symptoms.

 

ACUVUE® MOIST contacts for astigmatism featuring  LACREON® technology

A closer look at Dual Action Technology

 

To maximize fitting success, see more instructional and educational videos below.

 

Why 1-DAY ACUVUE® MOIST for ASTIGMATISM?

1-DAY ACUVUE® MOIST for ASTIGMATISM offers wider parameter coverage and first fit success, which means satisfying more patients.

80.5% wider parameter coverage for astigmatism patients
 

Wide coverage accommodates over 80.5% of Astigmatic patients

Image of a stop watch showing how easy it is to fit your  ACUVUE® contact lenses
 

Quick fit in 60 seconds**

90% of patients fit their contacts the first time
 

First fit nearly 90% of the time†1

More reasons to choose 1-DAY ACUVUE® MOIST for ASTIGMATISM

Excellent safety and health record

1-DAY ACUVUE® MOIST has an excellent health and safety record.

In a year-long observational study no serious or infiltrative event in 570 patients wearing lenses

UV blocking

1-DAY ACUVUE® MOIST blocks appproximately 97% of UVB and 82% UVA rays.

ACUVUE® contact lenses block 82 percent of UVA rays     
ACUVUE® contacts block 97% of UVB rays

Oxygen benefits in hydrogels

Dr. Noel Brennan, Clinical Research Fellow & Global Platform Lead of Myopia Control at Johnson & Johnson Vision Care, Inc. discusses oxygen needs in daily lens wear.

Open-eye oxygen needs of the central cornea5-7

In a corneal swelling investigation, 1-DAY ACUVUE® MOIST wearers showed4: <1.5% swelling across the cornea comparable to no lens wear and clinically insignificant levels of hyperemia.

Graph showing ACUVUE® MOIST wearers showed less swelling across the cornea comparable to no lens wear

Lens Details

Parameters

8.5 mm base curve/14.5 mm diameter

SEE MORE

Low minus power range:
Plano to -6.00D (0.25D steps)

CYL: -0.75, -1.25, -1.75
AXIS: 10°, 20°, 60°, 70°, 80°, 90°, 100°, 110°, 120°, 160°, 170°, 180°
CYL: -2.25
AXIS: 20°, 90°, 160°, 180°


High minus power range:
-6.50D to -9.00D (0.50D steps)


CYL: -0.75, -1.25, -1.75
AXIS: 10°, 20°, 60°, 70°, 80°, 90°, 100°, 110°, 120°, 160°, 170°, 180°
CYL: -2.25
AXIS: 20°, 90°, 160°, 180°


Plus power range:
+0.25D to +4.00D (0.25D steps)


CYL: -0.75, -1.25, -1.75
Axis: 20°, 70°, 90°, 110°, 160°, 180°

SEE LESS

Wear & replace schedule

Daily disposable

Lens material etafilcon A

Technology LACREON® Technology & BLINK STABILIZED®

Dk/t (edge-corrected)*2 23.8 x 10-9

Water content 58%

FDA classification Group 4

UV blocker Class 2

Center thickness at -3.00D (mm) 0.090

Inside-out mark No

Visibility tint Yes

Package size 30 or 90 lenses

Parameters

8.5 mm base curve/14.5 mm diameter

SEE MORE

Low minus power range:
Plano to -6.00D (0.25D steps)

CYL: -0.75, -1.25, -1.75
AXIS: 10°, 20°, 60°, 70°, 80°, 90°, 100°, 110°, 120°, 160°, 170°, 180°
CYL: -2.25
AXIS: 20°, 90°, 160°, 180°


High minus power range:
-6.50D to -9.00D (0.50D steps)


CYL: -0.75, -1.25, -1.75
AXIS: 10°, 20°, 60°, 70°, 80°, 90°, 100°, 110°, 120°, 160°, 170°, 180°
CYL: -2.25
AXIS: 20°, 90°, 160°, 180°


Plus power range:
+0.25D to +4.00D (0.25D steps)


CYL: -0.75, -1.25, -1.75
Axis: 20°, 70°, 90°, 110°, 160°, 180°

SEE LESS

Wear & replace schedule

Daily disposable

Additional 1-DAY ACUVUE® MOIST Products

1-DAY ACUVUE® MOIST family provides continuity of care across a broad range of patients.

Ratings and Reviews

 
 

Young G et al. Prevalence of astigmatism in relation to soft contact lens fitting. Eye & Contact Lens. 2011 ;37(1):20-25.

Wiggins NP, Daum KM. Visual discomfort and astigmatic refractive errors in VDT use. J Am Optom Assoc.1991 ;62(9):680-684.

* In an online survey of 501 new and existing contact lens wearers in the United States, 47.4% of patients showed astigmatism of 0.750 in at least one eye.

** Over 90% of lenses stabilized within 10 degrees of zero rotation within 60 seconds.

1 After 3 minutes, 85% of all BLINK STABILIZED® Design lenses oriented within 5 degrees, 97% within 10 degrees. 88% of all BLINK STABILIZED® Design contact lenses were fitted in the first attempt, and 99.5% within 2 trial fittings.

*1Based on in vitro data; clinical studies have not been done directly linking differences in lysozyme profile with specific clinical benefits.

*1Suwala M, Glasier MA, Subbaraman LN, Jones L. Quantity and conformation of lysozyme deposited on conventional and silicone hydrogel contact lens materials using an in vitro model. Eye Contact Lens. 2007;33(3):138-143.

4 Chalmers RL, Hickson-Curran SB, Keay L, Gleason W J, Albright R. Rates of adverse events with hydrogel and silicone hydrogel daily disposable lenses in a large post-market surveillance registry-The TEMPO Registry. Invest Opthamol Vis Sci. 2015. In press.

*** Equivalent to over 471 years of patient wear. In a study designed to observe ''real-life'' contact lens fitting and wearing behaviors, patients prescribed 1-DAY ACUVUE® MOIST were followed as part of a 1-year observational product registry. Patients who were at least 8 years of age, provided consent/assent and who agreed to register for the study completed questionnaires 2 weeks, 4 months, and 12 months after purchasing a lens supply. Adverse events were reported by subjects via the questionnaires if they responded ''yes'' to the question, ''Since we last contacted you, have you experienced a red or painful eye that required a visit to an eye doctor or emergency room?'' All ''yes'' responses were followed and reviewed independently by three expert, masked clinicians. Eighty-one percent (81 o/o) of the subjects prescribed 1-DAY ACUVUE® MOIST completed the 12-month survey. This observational/surveillance registry relied on patient reports of symptomatic adverse events that led them to seek clinical care. These results should be considered in conjunction with other clinical results on the safety and efficacy of daily disposable etafilcon A contact lenses, which also generally show low rates of such events. Although no symptomatic infiltrative events were reported in this study, such events can occur with daily disposable lenses, including 1-DAY ACUVUE® MOIST, as noted in the product labeling.

† UV-blocking percentages are based on an average across the wavelength spectrum. Helps protect against transmission of harmful UV radiation to the cornea and into the eye.

Class 2: Must transmit less than 50% of UVA and 5% (<5%) UVB. UV-blocking percentages are based on an average across the wavelength spectrum. 

WARNING: UV-absorbing contact lenses are NOT substitutes for protective UV-absorbing eyewear such as UVabsorbing goggles or sunglasses, because they do not completely cover the eye and surrounding area. You should continue to use UV-absorbing eyewear as directed. NOTE: Long-term exposure to UV radiation is one of the risk factors associated with cataracts. Exposure is based on a number of factors such as environmental conditions (altitude, geography, cloud cover) and personal factors (extent and nature of outdoor activities). UV-blocking contact lenses help provide protection against harmful UV radiation. However, clinical studies have not been done to demonstrate that wearing UV-blocking contact lenses reduces the risk of developing cataracts or other eye disorders. Consult your eye care practitioner for more information.

Holden B, Mertz G. Critical oxygen levels to avoid corneal edema for daily and extended wear contact lenses. Invest Ophthalmol Vis Sci. 1984;25(10):1161-1167.

6 Morgan PB, Brennan N, Maldenado-Codina C, et al. Central and peripheral oxygen transmissibility thresholds to avoid corneal swelling during open eye soft contact lens wear. J Biomed Mater Res B Appl Biomater. 2010;92(2):361-365.

7 Moezzi A et al. Open-eye corneal swelling with etafilcon A daily disposable hydrogel contact lens compared to no lens wear [poster]. Presented at: BCLA 2014.

*2 Oxygen transmissibility at center - 3.00D lens using boundary-corrected, edge-corrected Dk values. Units: (cm/sec) (ml O2/ml x mm Hg) at 35° C.

ACUVUE® Brand Contact Lenses are indicated for vision correction. As with any contact lens, eye problems, including corneal ulcers, can develop. Some wearers may experience mild irritation, itching or discomfort. Lenses should not be prescribed if patients have any eye infection, or experience eye discomfort, excessive tearing, vision changes, redness or other eye problems. Consult the package insert for complete information. Complete information is also available by visiting acuvueprofessional.com or by calling: In North America: Johnson & Johnson Vision Care, Inc. at 1-800-843-2020.

BACK Close

Login

BACK Close
BACK Close

Link to orderacuvue.com

Access your orderacuvue.com account through MyACUVUE® Pro.

Log in to link your MyACUVUE® Pro to orderacuvue.com.

Don’t have MyACUVUE® Pro? Register.

BACK Close

Would you like to exit the survey without end ?

Quit survey Continue questionnaire
BACK Close

Are you sure you want to cancel your subscription?

You will still be responsible for any fees contracted or accrued on your account, and there are no refunds. You may continue to use your services until your contract end date on [SERVICE END DATE].

How many subscriptions do you want to unsubscribe from?[COMBO LICENSES]

Yes, Cancel No, go back
BACK Close

Why are we replacing UPP?

We are discontinuing UPP in order to renew and continue our commitment to advocate for the doctor-patient relationship and against legislation that threatens to deregulate the industry and undermine patient health.

We introduced UPP in 2014, and today a majority of patients are paying less for their ACUVUE® Brand Contact Lenses than two years ago. Since 2014, there have also been significant legal and legislative challenges to UPP across the country that are distracting our focus on emerging issues that could lead to deregulation of contact lenses. Proponents of deregulation advocate for harmful policies, such as online prescribing of contact lenses and extending contact lens prescription expiration limits. Opposing these efforts requires our undivided attention. 

Our new ACUVUE® Rewards Program replaces UPP and provides similar benefits—affordability, access, and patient retention.